{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:38:30Z","timestamp":1790091510644,"version":"4.0.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008319","name":"Fondation Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"publisher","award":["69HCL18-0527"],"award-info":[{"award-number":["69HCL18-0527"]}],"id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.autrev.2023.103420","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T11:53:43Z","timestamp":1692791623000},"page":"103420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["IFN-\u03b3: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies"],"prefix":"10.1016","volume":"22","author":[{"given":"Jonathan","family":"Thuner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Coutant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2023.103420_bb0005","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727","article-title":"Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases","volume":"95","author":"Allenbach","year":"2020","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.autrev.2023.103420_bb0010","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/rheumatology\/keaa021","article-title":"The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity","volume":"59","author":"Tansley","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103420_bb0015","doi-asserted-by":"crossref","first-page":"112661","DOI":"10.1016\/j.jim.2019.112661","article-title":"Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies","volume":"474","author":"Cavazzana","year":"2019","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2023.103420_bb0020","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fimmu.2019.00848","article-title":"Comparison of three immunoassays for the detection of myositis specific antibodies","volume":"10","author":"Mahler","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103420_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.773352","article-title":"Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies","volume":"12","author":"Nombel","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103420_bb0030","article-title":"Pathogenesis of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a concise review with an emphasis on type I interferon system","volume":"8","author":"Hu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2023.103420_bb0035","first-page":"keac627","article-title":"Changes in anti-MDA5 antibody titres and serum cytokine levels before and after diagnosis of anti-MDA5 antibody-positive dermatomyositis","author":"Kogami","year":"2022","journal-title":"Rheumatology."},{"issue":"12","key":"10.1016\/j.autrev.2023.103420_bb0040","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","article-title":"Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease","volume":"53","author":"Gono","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2023.103420_bb0045","first-page":"275","article-title":"Potential role of type I interferon\/IP-10 axis in the pathogenesis of anti-MDA5 antibody-positive dermatomyositis","volume":"41","author":"Kokuzawa","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103420_bb0050","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.rmed.2015.07.004","article-title":"Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140\/MDA5 antibody positive amyopathic dermatomyositis","volume":"109","author":"Takada","year":"2015","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103420_bb0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13075-018-1737-2","article-title":"Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis","volume":"20","author":"Ishikawa","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2023.103420_bb0060","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1038\/s41467-022-34145-4","article-title":"Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications","volume":"13","author":"Ye","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.autrev.2023.103420_bb0065","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10067-020-05339-2","article-title":"Hierarchical cluster analysis of cytokine profiles reveals a cutaneous vasculitis-associated subgroup in dermatomyositis","volume":"40","author":"Bai","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103420_bb0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103420_bb0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","article-title":"Type I interferon in systemic lupus erythematosus and other autoimmune diseases","volume":"25","author":"Banchereau","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2023.103420_bb0080","article-title":"IFN-\u03b3, should not be ignored in SLE","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103420_bb0085","doi-asserted-by":"crossref","first-page":"102831","DOI":"10.1016\/j.jaut.2022.102831","article-title":"Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production","volume":"130","author":"Coutant","year":"2022","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.autrev.2023.103420_bb0090","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/eji.201545544","article-title":"Pathogenic functions of B cells in autoimmune diseases: IFN-\u03b3 production joins the criminal gang","volume":"45","author":"Fillatreau","year":"2015","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103420_bb0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/JLB.4MIR0420-619RR","article-title":"Changing the paradigm of IFN-\u03b3 at the interface between innate and adaptive immunity: macrophage-derived IFN-\u03b3","volume":"108","author":"Mezouar","year":"2020","journal-title":"J Leukoc Biol"},{"issue":"20","key":"10.1016\/j.autrev.2023.103420_bb0100","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1073\/pnas.1116058109","article-title":"Cytotoxic immunological synapses do not restrict the action of interferon-\u03b3 to antigenic target cells","volume":"109","author":"Sanderson","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7425","key":"10.1016\/j.autrev.2023.103420_bb0105","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11581","article-title":"Novel Foxo1-dependent transcriptional programs control T(reg) cell function","volume":"491","author":"Ouyang","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.autrev.2023.103420_bb0110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124427","article-title":"TIGIT signaling restores suppressor function of Th1 Tregs","volume":"4","author":"Lucca","year":"2019","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.autrev.2023.103420_bb0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm.2389","article-title":"Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease","volume":"17","author":"Dominguez-Villar","year":"2011","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.autrev.2023.103420_bb0120","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.4049\/jimmunol.1003099","article-title":"Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes","volume":"186","author":"McClymont","year":"2011","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103420_bb0125","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4049\/jimmunol.1502276","article-title":"Production of proinflammatory cytokines by monocytes in liver-transplanted recipients with De Novo autoimmune hepatitis is enhanced and induces TH1-like regulatory T cells","volume":"196","author":"Arterbery","year":"2016","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103420_bb0130","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103420_bb0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nri3857","article-title":"Antibody-independent functions of B cells: a focus on cytokines","volume":"15","author":"Shen","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103420_bb0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/cr.2013.155","article-title":"Identification of IFN-\u03b3-producing innate B cells","volume":"24","author":"Bao","year":"2014","journal-title":"Cell Res"},{"issue":"11","key":"10.1016\/j.autrev.2023.103420_bb0145","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1136\/ard.2011.153312","article-title":"Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis","volume":"70","author":"Yeo","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2023.103420_bb0150","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/eji.201445036","article-title":"B cells expressing IFN-\u03b3 suppress Treg-cell differentiation and promote autoimmune experimental arthritis","volume":"45","author":"Olalekan","year":"2015","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103420_bb0155","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2567.2008.02905.x","article-title":"Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18","volume":"126","author":"Darwich","year":"2009","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.autrev.2023.103420_bb0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/icb.2012.9","article-title":"The interferons and their receptors - distribution and regulation","volume":"90","author":"de Weerd","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2023.103420_bb0165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fimmu.2013.00202","article-title":"IFN signaling: how a non-canonical model led to the development of IFN mimetics","volume":"4","author":"Johnson","year":"2013","journal-title":"Front Immunol"},{"issue":"16","key":"10.1016\/j.autrev.2023.103420_bb0170","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1073\/pnas.0710814105","article-title":"Multiple kinases in the interferon-gamma response","volume":"105","author":"Watling","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.autrev.2023.103420_bb0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103420_bb0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cytogfr.2009.02.004","article-title":"Interferon-gamma: a historical perspective","volume":"20","author":"Billiau","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"10.1016\/j.autrev.2023.103420_bb0185","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1084\/jem.158.3.670","article-title":"Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity","volume":"158","author":"Nathan","year":"1983","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.autrev.2023.103420_bb0190","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2023.103420_bb0195","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103420_bb0200","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.autrev.2023.103420_bb0205","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/eji.200838913","article-title":"IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis","volume":"39","author":"Chang","year":"2009","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103420_bb0210","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.177.3.1416","article-title":"Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection","volume":"177","author":"Cruz","year":"2006","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103420_bb0215","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/ar2960","article-title":"Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis","volume":"12","author":"Page","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.autrev.2023.103420_bb0220","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ijc.25350","article-title":"Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis","volume":"128","author":"Briesemeister","year":"2011","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.autrev.2023.103420_bb0225","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm0498-408","article-title":"Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma","volume":"4","author":"R\u00fcegg","year":"1998","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.autrev.2023.103420_bb0230","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1182\/blood.V87.9.3877.bloodjournal8793877","article-title":"Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10","volume":"87","author":"Sgadari","year":"1996","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.autrev.2023.103420_bb0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.55563\/clinexprheumatol\/ubov8b","article-title":"Evaluation of biomarkers related to endothelial dysfunction: proof of vasculopathy in anti-melanoma differentiation-associated gene 5 dermatomyositis","volume":"39","author":"He","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2023.103420_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24726","article-title":"Roles of biomarkers in anti-MDA5-positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease","volume":"36","author":"Li","year":"2022","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"10.1016\/j.autrev.2023.103420_bb0245","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s10067-019-04457-w","article-title":"Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody","volume":"38","author":"Jiang","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103420_bb0250","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/rheumatology\/kez185","article-title":"Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD","volume":"58","author":"Horiike","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103420_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.745233","article-title":"KL-6 as an immunological biomarker predicts the severity, progression, acute exacerbation, and poor outcomes of interstitial lung disease: a systematic review and meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103420_bb0260","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/rheumatology\/keq073","article-title":"Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2023.103420_bb0265","first-page":"291","article-title":"Intensive induction therapy combining tofacitinib, rituximab and plasma exchange in severe anti-melanoma differentiation-associatedprotein-5 antibody-positive dermatomyositis","volume":"41","author":"Shirai","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103420_bb0270","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00296-019-04255-2","article-title":"Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis","volume":"39","author":"Nagashima","year":"2019","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.autrev.2023.103420_bb0275","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood."},{"issue":"9","key":"10.1016\/j.autrev.2023.103420_bb0280","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103420_bb0285","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/cei.13404","article-title":"A high level of serum neopterin is associated with rapidly progressive interstitial lung disease and reduced survival in dermatomyositis","volume":"199","author":"Peng","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2023.103420_bb0290","doi-asserted-by":"crossref","first-page":"1151695","DOI":"10.3389\/fimmu.2023.1151695","article-title":"Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients","volume":"14","author":"Qian","year":"2023","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103420_bb0295","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1093\/rheumatology\/keaa266","article-title":"The characteristics of lymphocytes in patients positive for anti-MDA5 antibodies in interstitial lung disease","volume":"59","author":"Huang","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2023.103420_bb0300","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2478\/rir-2022-0022","article-title":"A preliminary study of frequency and clinical relevance of cytotoxic peripheral CD4 and CD8 T cells in patients with anti-MDA5 positive dermatomyositis","volume":"3","author":"Jia","year":"2022","journal-title":"Rheumatol Immunol Res"},{"issue":"Database issue","key":"10.1016\/j.autrev.2023.103420_bb0305","first-page":"D1040","article-title":"Interferome v2.0: an updated database of annotated interferon-regulated genes","volume":"41","author":"Rusinova","year":"2013","journal-title":"Nucl Acids Res"},{"issue":"9","key":"10.1016\/j.autrev.2023.103420_bb0310","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.autrev.2023.103420_bb0315","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/rheumatology\/key188","article-title":"Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis","volume":"57","author":"Kurasawa","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.autrev.2023.103420_bb0320","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J Cell Physiol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103420_bb0325","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/crj.13616","article-title":"Soluble CD206 levels correlate with disease deterioration and predict prognosis of anti-MDA5 antibody-positive dermatomyositis related interstitial lung disease","volume":"17","author":"Li","year":"2023","journal-title":"Clin Respir J"},{"issue":"2","key":"10.1016\/j.autrev.2023.103420_bb0330","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.trsl.2010.11.007","article-title":"Synergistic induction of CX3CL1 by interleukin-1\u03b2 and interferon-\u03b3 in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathways","volume":"157","author":"Isozaki","year":"2011","journal-title":"Transl Res"},{"issue":"1","key":"10.1016\/j.autrev.2023.103420_bb0335","doi-asserted-by":"crossref","first-page":"16833","DOI":"10.1038\/s41598-017-17007-8","article-title":"Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration","volume":"7","author":"Ishida","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.autrev.2023.103420_bb0340","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3390\/biomedicines9121747","article-title":"Is the macrophage phenotype determinant for fibrosis development?","volume":"9","author":"Lis-L\u00f3pez","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.autrev.2023.103420_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.624746","article-title":"The macrophage response is driven by mesenchymal stem cell-mediated metabolic reprogramming","volume":"12","author":"Luque-Campos","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2023.103420_bb0350","doi-asserted-by":"crossref","first-page":"155209","DOI":"10.1016\/j.cyto.2020.155209","article-title":"Prognostic evaluation of serum osteopontin in patients with anti-MDA5 antibody-positive dermatomyositis associated interstitial lung disease","volume":"135","author":"Gao","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.autrev.2023.103420_bb0355","doi-asserted-by":"crossref","first-page":"7675437","DOI":"10.1155\/2016\/7675437","article-title":"Osteopontin bridging innate and adaptive immunity in autoimmune diseases","volume":"2016","author":"Clemente","year":"2016","journal-title":"J Immunol Res"},{"issue":"9","key":"10.1016\/j.autrev.2023.103420_bb0360","article-title":"Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis","volume":"2","author":"A","year":"2005","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.autrev.2023.103420_bb0365","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/107999003321829971","article-title":"IFN-gamma induction of osteopontin expression in human monocytoid cells","volume":"23","author":"Li","year":"2003","journal-title":"J Interferon Cytokine Res"},{"issue":"5","key":"10.1016\/j.autrev.2023.103420_bb0370","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1165\/ajrcmb.24.5.4064","article-title":"Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin","volume":"24","author":"Chen","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103420_bb0375","doi-asserted-by":"crossref","first-page":"L1255","DOI":"10.1152\/ajplung.00303.2002","article-title":"Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis","volume":"285","author":"Segel","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.autrev.2023.103420_bb0380","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.addr.2018.06.004","article-title":"Repurposing of gamma interferon via inhalation delivery","volume":"133","author":"Smaldone","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.autrev.2023.103420_bb0385","doi-asserted-by":"crossref","first-page":"9223883","DOI":"10.1155\/2022\/9223883","article-title":"Elevated serum IGFBP-2 and CTGF levels are associated with disease activity in patients with dermatomyositis","volume":"2022","author":"Yang","year":"2022","journal-title":"Dis Markers"},{"issue":"9","key":"10.1016\/j.autrev.2023.103420_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045430","article-title":"IFN-\u03b3 and TNF-\u03b1 synergize to inhibit CTGF expression in human lung endothelial cells","volume":"7","author":"Laug","year":"2012","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.autrev.2023.103420_bb0395","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12016-015-8496-5","article-title":"Cutaneous manifestations in dermatomyositis: key clinical and serological features\u2014a comprehensive review","volume":"51","author":"Muro","year":"2016","journal-title":"Clinic Rev Allerg Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103420_bb0400","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103420_bb0405","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/ijd.15204","article-title":"Inverse Gottron\u2019s papules in patients with dermatomyositis: an underrecognized but important sign for interstitial lung disease","volume":"60","author":"Irie","year":"2021","journal-title":"Int J Dermatol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103420_bb0410","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/jid.2012.54","article-title":"Gottron\u2019s papules exhibit dermal accumulation of CD44 variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature","volume":"132","author":"Kim","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"3\u20134","key":"10.1016\/j.autrev.2023.103420_bb0415","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12079-009-0068-0","article-title":"The role of osteopontin in inflammatory processes","volume":"3","author":"Lund","year":"2009","journal-title":"J Cell Commun Signal"},{"issue":"9","key":"10.1016\/j.autrev.2023.103420_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012700","article-title":"CXCL10 can inhibit endothelial cell proliferation independently of CXCR3","volume":"5","author":"Campanella","year":"2010","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.autrev.2023.103420_bb0425","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","article-title":"Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study","volume":"147","author":"Hamaguchi","year":"2011","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.autrev.2023.103420_bb0430","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.21992","article-title":"Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum","volume":"65","author":"Hall","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.autrev.2023.103420_bb0435","doi-asserted-by":"crossref","first-page":"C1183","DOI":"10.1152\/ajpcell.00568.2007","article-title":"Endogenous interferon-gamma is required for efficient skeletal muscle regeneration","volume":"294","author":"Cheng","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103420_bb0440","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0736-0266(03)00059-7","article-title":"Gamma interferon as an antifibrosis agent in skeletal muscle","volume":"21","author":"Foster","year":"2003","journal-title":"J Orthop Res"},{"issue":"1","key":"10.1016\/j.autrev.2023.103420_bb0445","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s11658-023-00439-8","article-title":"IFN-\u03b3 blockade after genetic inhibition of PD-1 aggravates skeletal muscle damage and impairs skeletal muscle regeneration","volume":"28","author":"Zhuang","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.autrev.2023.103420_bb0450","article-title":"Rituximab in the treatment of interstitial lung diseases related to anti-melanoma differentiation-associated gene 5 dermatomyositis: a systematic review","volume":"12","author":"He","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103420_bb0455","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003238","article-title":"Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab","volume":"9","author":"Ostendorf","year":"2023","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.autrev.2023.103420_bb0460","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.chest.2022.08.2209","article-title":"Successful rescue therapy with daratumumab in rapidly progressive interstitial lung disease caused by MDA5-positive dermatomyositis","volume":"163","author":"Holzer","year":"2023","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.autrev.2023.103420_bb0465","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/art.41906","article-title":"A decade of JAK inhibitors: what have we learned and what may be the future?","volume":"73","author":"Liu","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103420_bb0470","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13075-019-1964-1","article-title":"Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations","volume":"21","author":"McInnes","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103420_bb0475","article-title":"Tofacitinib for new-onset adult patients with anti-melanoma differentiation-associated 5 gene antibody positive dermatomyositis","volume":"16","author":"Wang","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103420_bb0480","doi-asserted-by":"crossref","DOI":"10.1097\/RHU.0000000000002010","article-title":"Efficacy and safety of Tofacitinib in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis","author":"Li","year":"2023","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103420_bb0485","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard-2022-223739","article-title":"Efficacy and safety of emapalumab in macrophage activation syndrome","volume":"82","author":"De Benedetti","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103420_bb0490","article-title":"The multi-modal effect of the anti-fibrotic drug Pirfenidone on NSCLC","volume":"9","author":"Marwitz","year":"2020","journal-title":"Front Oncol [Internet]"},{"key":"10.1016\/j.autrev.2023.103420_bb0495","article-title":"The efficacy and safety of Pirfenidone combined with immunosuppressant therapy in connective tissue disease-associated interstitial lung disease: a 24-week prospective controlled cohort study","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.autrev.2023.103420_bb0500","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","article-title":"High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus","volume":"21","author":"Oke","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2023.103420_bb0505","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4049\/jimmunol.181.3.2211","article-title":"Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator\/B cell-activating factor\/TNF ligand superfamily-13B","volume":"181","author":"Harigai","year":"2008","journal-title":"J Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:13:29Z","timestamp":1778620409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":101,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1568997223001544"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103420","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFN-\u03b3: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103420"}}